Abstract:The reaction of the vanadyl ion (VO2+) with imidazole-4-carboxylic acid (Im4COOH), imidazole-2-carboxylic acid (Im2COOH) and methylimidazole-2-carboxylic acid (MeIm2COOH), respectively, in the presence of small bioligands (bL) [oxalate (Ox), lactate (Lact), citrate (Cit) and phosphate (Phos)] and high-molecular-weight (HMW) human serum proteins [albumin (HSA) and transferrin (hTf)] were studied in aqueous solution using potentiometric acid–base titrations. The species distribution diagrams for the high-molecular-mass (HMM) proteins with oxidovanadium(IV) under physiological pH were dominated by VO(HMM)2, VOL(HMM) for unsubstituted ligands (L− = Im4COO− and Im2COO−). However, for the N-substituted MeIm2COOH, the species distribution diagrams under physiological pH were dominated by VOL2, VO(HMM)2 and VO2L2(HMM). These species were further confirmed by LC-MS, MALDI-TOF-MS and EPR studies. The glucose-stimulated insulin secretion (GSIS) action of the complexes was investigated using INS-1E cells at a 1 μM concentration, which was established through cytotoxicity studies via the MTT assay. The neutral complexes, especially VO(MeIm2COO)2, showed promising results in the stimulation of insulin secretion than the cationic [VO(MeIm2CH2OH)2]2+ complex and the vanadium salt. Oxidovanadium(IV) complexes reduced insulin stimulation significantly under normoglycaemic levels but showed positive effects on insulin secretion under hyperglycaemic conditions (33.3 mM glucose media). The islets exposed to oxidovanadium(IV) complexes under hyperglycaemic conditions displayed a significant increase in the stimulatory index with 1.19, 1.75, 1.53, 1.85, 2.20 and 1.29 observed for the positive control (sulfonylurea:gliclazide), VOSO4, VO(Im4COO)2, VO(Im2COO)2, VO(MeIm2COO)2 and VO(MeIm2CH2OH)22+, respectively. This observation showed a potential further effect of vanadium complexes towards type 2 diabetes and has been demonstrated for the first time in this study.

Synthesis, Characterization, and Insulin-Enhancing of Vanadium(V) Complexes with Similar Schiff Base Ligands

Synthesis, Crystal Structures and Insulin-Like Activity of Two New Oxidovanadium(v) Complexes with Aroylhydrazones and Maltol Mixed-Ligands

Insulin-enhancing Activity of a Dinuclear Vanadium Complex: 5-Chloro-salicylaldhyde Ethylenediamine Oxovanadium(v) and Its Permeability and Cytotoxicity.

Synthesis, Structures and Insulin-Like Activity of Oxidovanadium(v) Complexes with Aroylhydrazones and Ethylmaltol Mixed-Ligands

Biospeciation of Oxidovanadium(IV) Imidazolyl–Carboxylate Complexes and Their Action on Glucose-Stimulated Insulin Secretion in Pancreatic Cells

Synthesis and Characterization of the Mono- and Di-Meric Complexes of Mn(Iii) with Tridentate Schiff Base Ligands: L (L = N-(3-Hydroxypropyl) Salicydenimine, N-(3-Hydroxypropyl)-3-Methoxyl-Salicydenimine)

8-Hydroxyquinoline Coordinated Vanadium(V) Complexes with Schiff Bases: Synthesis, Characterization, and Crystal Structures

Synthesis, Characterization and Anti-Diabetic Therapeutic Potential of a New Benzyl Acid-Derivatized Kojic Acid Vanadyl Complex

Synthesis, Crystal Structures, and Biological Activity of Oxovanadium(V) Complexes with Similar Tridentate Hydrazone Ligands

Syntheses, Characterization, and Structures of Vanadium(v) Complexes with Similar Tridentate Hydrazone and Bidentate Benzohydroxamate Ligands

Synthesis, Characterization, and Crystal Structures of New Oxovanadium(V) Complexes with Mixed Nicotinohydrazone and 8-Hydroxyquinoline Ligands

Syntheses, Crystal Structures and Insulin-like Activity of Maltolato-and Ethylmaltolato-Coordinated Oxovanadium(V) Complexes Derived from 4-Fluoro-N' -(3-ethoxy-2-hydroxybenzylidene)benzohydrazide

Vanadium(V) Complexes Derived from N'-(3-Bromo-2-hydroxybenzylidene)-2-methylbenzohydrazide and N'-(3-Bromo-2-hydroxybenzylidene)-2-methoxybenzohydrazide: Syntheses and Structures

Synthesis and Structural Characterization of Oxovanadium(v) Complexes with Mixed Tridentate Benzohydrazone and Bidentate No Ligands

Synthesis, Characterization and Crystal Structure of Cyclic Vanadate Complexes with Monosaccharide Derivatives Having a Free Adjacent Diol System

Syntheses, Characterization, and Urease Inhibition of Oxidovanadium(V) Complexes with Tridentate Hydrazone and Bidentate Benzohydroxamate Ligands

Effect of the Chloro-Substitution on Lowering Diabetic Hyperglycemia of Vanadium Complexes with Their Permeability and Cytotoxicity.

Synthesis and X-Ray Structures of Di- and Mono-Nuclear Oxovanadium(V) Complexes Derived from Aroylhydrazones

Hydrazone-flavonol based oxidovanadium( V ) complexes: Synthesis, characterization and antihyperglycemic activity of chloro derivative in vivo

Binding of Vanadium Compounds Perturbs Conformation and Aggregation State of Insulin

A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats